Pliant Therapeutics, Inc.

PLRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$93,732$86,820$91,936$71,188
Short-Term Investments$148,065$176,053$213,709$284,536
Receivables$0$1,535$1,683$2,302
Inventory$0$0$0$0
Other Curr. Assets$3,791$3,036$3,863$4,238
Total Curr. Assets$245,588$267,444$311,191$362,264
Property Plant & Equip (Net)$29,138$30,507$31,670$32,768
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,874$1,873$1,909$1,917
Total NC Assets$31,012$32,380$33,579$34,685
Other Assets$0$0$0$0
Total Assets$276,600$299,824$344,770$396,949
Liabilities
Payables$485$1,384$5,622$5,960
Short-Term Debt$1,187$1,225$771$542
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,952$17,982$21,810$26,716
Total Curr. Liab.$17,624$20,591$28,203$33,218
LT Debt$58,670$59,151$59,403$59,650
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$58,670$59,151$59,403$59,650
Other Liabilities$0$0$0$0
Cap. Leases$29,418$30,016$29,890$29,981
Total Liabilities$76,294$79,742$87,606$92,868
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$835,819-$809,518-$766,218-$710,052
AOCI$34-$1$159$321
Other Equity$1,036,085$1,029,595$1,023,217$1,013,806
Total Equity$200,306$220,082$257,164$304,081
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$276,600$299,824$344,770$396,949
Net Debt-$33,875-$26,444-$31,762-$10,996